Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Houke M, Klomp"'
Autor:
Jana S. Hopstaken, Julianne C. de Ruiter, Ronald A.M. Damhuis, Adrianus J. de Langen, Judi N.A. van Diessen, Houke M. Klomp, Elisabeth G. Klompenhouwer, Koen J. Hartemink
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100404- (2021)
Objectives: Several treatment modalities are available for patients with stage I non-small cell lung cancer (NSCLC). Over the past decade, these treatment modalities have been further investigated and might have changed current treatment regimens. In
Externí odkaz:
https://doaj.org/article/f60f54ad10b3414f9748f599348911db
Autor:
Talya L. Dayton, Nicolas Alcala, Laura Moonen, Lisanne den Hartigh, Lise Mangiante, Lisa Lap, Antonella F. M. Dost, Joep Beumer, Sonja Levy, Rachel S. van Leeuwaarde, Wenzel M. Hackeng, Kris Samsom, Catherine Voegele, Alexandra Sexton-Oates, Harry Begthel, Jeroen Korving, Lisa Hillen, Lodewijk A. A. Brosens, Sylvie Lantuejoul, Sridevi Jaksani, Niels F.M. Kok, Koen J. Hartemink, Houke M. Klomp, Inne H.M. Borel Rinkes, Anne-Marie Dingemans, Gerlof D. Valk, Menno R. Vriens, Wieneke Buikhuisen, José van den Berg, Margot Tesselaar, Jules Derks, Ernst Jan Speel, Matthieu Foll, Lynnette Fernández-Cuesta, Hans Clevers
SUMMARYNeuroendocrine neoplasms (NENs) comprise well-differentiated neuroendocrine tumors and poorly-differentiated carcinomas. Treatment options for patients with NENs are limited, in part due to lack of accurate models. To address this need we esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3bc40d9a79e2adf83c5f5eab03f44e6
https://doi.org/10.1101/2022.10.31.514549
https://doi.org/10.1101/2022.10.31.514549
Autor:
Vincent van der Noort, José Belderbos, Max Dahele, Pieter J M Joosten, Houke M. Klomp, Jan W.A. Oosterhuis, Judi N.A. van Diessen, Chris Dickhoff, Koen J. Hartemink, Maarten Smeekens, Kim Monkhorst, Rachel C. Numan, Michel M van den Heuvel, Egbert F. Smit
Publikováno v:
Joosten, P J M, Dickhoff, C, van der Noort, V, Smeekens, M, Numan, R C, Klomp, H M, van Diessen, J N A, Belderbos, J S A, Smit, E F, Monkhorst, K, Oosterhuis, J W A, van den Heuvel, M M, Dahele, M & Hartemink, K J 2022, ' Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis ', Interactive Cardiovascular and Thoracic Surgery, vol. 34, no. 4, pp. 566-575 . https://doi.org/10.1093/icvts/ivab291
Interactive Cardiovascular and Thoracic Surgery, 34(4), 566-575. European Association for Cardio-Thoracic Surgery
Interactive Cardiovascular and Thoracic Surgery, 34, 566-575
Interactive Cardiovascular and Thoracic Surgery, 34, 4, pp. 566-575
Interactive Cardiovascular and Thoracic Surgery, 34(4), 566-575. European Association for Cardio-Thoracic Surgery
Interactive Cardiovascular and Thoracic Surgery, 34, 566-575
Interactive Cardiovascular and Thoracic Surgery, 34, 4, pp. 566-575
OBJECTIVES Chemoradiotherapy (CRT) has been the backbone of guideline-recommended treatment for Stage IIIA non-small cell lung cancer (NSCLC). However, in selected operable patients with a resectable tumour, good results have been achieved with trimo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8679f6d2ca1b2de5b5871c4de635c59
https://research.vumc.nl/en/publications/c45f00c5-8293-47e1-bcb9-84e22d366dd3
https://research.vumc.nl/en/publications/c45f00c5-8293-47e1-bcb9-84e22d366dd3
Autor:
Ronald A M Damhuis, Pieter J M Joosten, Houke M. Klomp, Egbert F. Smit, Judi N.A. van Diessen, José Belderbos, Joop A de Langen, Koen J. Hartemink, A. A. F. A. Veenhof
Publikováno v:
Acta Oncologica, 59(7), 748-752. TAYLOR & FRANCIS LTD
Introduction: Concurrent chemoradiotherapy remains the main treatment strategy for patients with stage IIIA non-small cell lung cancer (NSCLC); stage cT3N1 or cT4N0-1 may be eligible for surgery and potentially resectable stage IIIA (N2) NSCLC for ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3f3dd63c817de1f84d6a726c702000
https://doi.org/10.1080/0284186x.2020.1757150
https://doi.org/10.1080/0284186x.2020.1757150
Autor:
A.J. de Langen, Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, A. A. F. A. Veenhof, Kim Monkhorst, Houke M. Klomp, Koen J. Hartemink, Egbert F. Smit
Publikováno v:
Lung Cancer, 161, 141-151. ELSEVIER IRELAND LTD
Lung Cancer, 161, 141-151. Elsevier Ireland Ltd
Joosten, P J M, de Langen, A J, van der Noort, V, Monkhorst, K, Klomp, H M, Veenhof, A A F A, Dickhoff, C, Smit, E F & Hartemink, K J 2021, ' The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer ', Lung Cancer, vol. 161, pp. 141-151 . https://doi.org/10.1016/j.lungcan.2021.09.019
Lung Cancer, 161, 141-151. Elsevier Ireland Ltd
Joosten, P J M, de Langen, A J, van der Noort, V, Monkhorst, K, Klomp, H M, Veenhof, A A F A, Dickhoff, C, Smit, E F & Hartemink, K J 2021, ' The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer ', Lung Cancer, vol. 161, pp. 141-151 . https://doi.org/10.1016/j.lungcan.2021.09.019
Objectives Patients with advanced stage non-small cell lung cancer (NSCLC) are generally considered incurable. The mainstay of treatment for these patients is systemic therapy. The addition of local treatment, including surgery, remains controversial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b297e0485ea517b32856fb3b24784d
https://doi.org/10.1016/j.lungcan.2021.09.019
https://doi.org/10.1016/j.lungcan.2021.09.019
Autor:
A.N. Scholten, Augustinus D.G. Krol, Aisha Miah, Nina L. Jebsen, Elizabeth H. Baldini, Uta Flucke, Khin Thway, Houke M. Klomp, Piet van den Ende, Winan J. van Houdt, Hester van Boven, Erik van Werkhoven, Yvonne Schrage, Judith V.M.G. Bovée, Jos A. van der Hage, Jan F. Ubbels, Rick L. Haas, Pètra M. Braam, Johannes J. Bonenkamp, Shane Zaidi, Øyvind S. Bruland, Jules Lansu, Winette T. A. van der Graaf, Frits van Coevorden
Publikováno v:
JAMA Oncology, 7(1):205865. American Medical Association
JAMA Oncology, 7(1). American Medical Association
JAMA Oncology, 7(1). AMER MEDICAL ASSOC
Jama Oncology, 7
JAMA Oncol
JAMA oncology, 7(1), 1-8. AMER MEDICAL ASSOC
Jama Oncology, 7, 1
JAMA Oncology, 7(1). American Medical Association
JAMA Oncology, 7(1). AMER MEDICAL ASSOC
Jama Oncology, 7
JAMA Oncol
JAMA oncology, 7(1), 1-8. AMER MEDICAL ASSOC
Jama Oncology, 7, 1
Item does not contain fulltext IMPORTANCE: Currently, preoperative radiotherapy for all soft-tissue sarcomas is identical at a 50-Gy dose level, which can be associated with morbidity, particularly wound complications. The observed clinical radiosens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501905765c7eae7ad18abaae3193aff4
https://doi.org/10.1001/jamaoncol.2020.5865
https://doi.org/10.1001/jamaoncol.2020.5865
Autor:
Houke M. Klomp, Ronald A M Damhuis, A. A. F. A. Veenhof, Koen J. Hartemink, J. R. de Ruiter, A.J. de Langen, Kim Monkhorst
Publikováno v:
Journal of Thoracic Oncology. 16:S703
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::602cdeb1a5d4df2c2875503bc8679b39
https://doi.org/10.1016/s1556-0864(21)01852-9
https://doi.org/10.1016/s1556-0864(21)01852-9
Autor:
Houke M. Klomp, Judi N.A. van Diessen, Elisabeth G. Klompenhouwer, Koen J. Hartemink, Jana S. Hopstaken, Adrianus J. de Langen, Julianne C. de Ruiter, Ronald A M Damhuis
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss, Pp 100404-(2021)
Objectives Several treatment modalities are available for patients with stage I non-small cell lung cancer (NSCLC). Over the past decade, these treatment modalities have been further investigated and might have changed current treatment regimens. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c93fa083b9bf86627e12c75906607ab5
https://doi.org/10.1016/j.ctarc.2021.100404
https://doi.org/10.1016/j.ctarc.2021.100404
Autor:
Houke M. Klomp, Rachel C. Numan, Jacobus A. Burgers, Johanna W. van Sandick, Michel W.J.M. Wouters, Martijn ten Berge, Paul Baas
Publikováno v:
Lung Cancer. 101:129-136
Quality of care (QoC) has a central role in our health care system. The aim of this review is to present a set of evidence-based quality indicators for the surgical treatment and postoperative management of lung cancer. A search was performed through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25f519d13f42e0a70c1c4975fba7c68
https://doi.org/10.1016/j.lungcan.2016.06.007
https://doi.org/10.1016/j.lungcan.2016.06.007
Autor:
Houke M. Klomp, Renato A. Valdés Olmos, Anthonie Zwijnenburg, Bart M Titulaer, Herman Rijna, Renske Konings, Matthijs H. van Gool, Martin P.L. Bard, Karolina Sikorska, Tjeerd S. Aukema
Publikováno v:
Annals of Nuclear Medicine. 30:362-368
In this study we evaluated the value of pre-operative glucose corrected maximum standard uptake value (GC-SUVmax) as prognostic factor in patients with early stage non-small cell lung cancer (NSCLC) after complete surgical resection. This study was d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::506b3f56569952435ef36973502b0cbf
https://doi.org/10.1007/s12149-016-1070-2
https://doi.org/10.1007/s12149-016-1070-2